ducovest

VBR:ARCA-Vanguard Small-Cap Value ETF - DNQ (USD)

ETF | Small Value | NYSE Arca

Last Closing

USD 191.88

Change

+0.98 (+0.51)%

Market Cap

USD 9.17B

Volume

0.36M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks to track the performance of a benchmark index that measures the investment return of small-capitalization value stocks. The fund employs an indexing investment approach designed to track the performance of the CRSP US Small Cap Value Index, a broadly diversified index of value stocks of small U.S. companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.

Company Website : www.vanguard.com

Currency: USD

Country : USA

Inception Date: 26/01/2004

Primary Benchmark: CRSP US Small Cap Value TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.08%

Management Expense Ratio: 0.07 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
TARS Tarsus Pharmaceuticals Inc 0.59 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-28 )

Largest Industry Peers for Small Value

Symbol Name Mer Price(Change) Market Cap
IJS iShares S&P Small-Cap 600 Valu.. 0.25 %

N/A

 USD 7.23B
SLYV SPDR® S&P 600 Small Cap Value.. 0.15 %

N/A

 USD 4.00B
DES WisdomTree U.S. SmallCap Divid.. 0.38 %

N/A

 USD 2.00B
RWJ Invesco S&P SmallCap 600 Reven.. 0.39 %

N/A

 USD 1.55B
VIOV Vanguard S&P Small-Cap 600 Val.. 0.20 %

N/A

 USD 1.28B
XSVM Invesco S&P SmallCap Value wit.. 0.39 %

N/A

 USD 0.78B
XSLV Invesco S&P SmallCap Low Volat.. 0.25 %

N/A

 USD 0.33B
RFV Invesco S&P MidCap 400® Pure .. 0.35 %

N/A

 USD 0.30B
RZV Invesco S&P SmallCap 600® Pur.. 0.35 %

N/A

 USD 0.22B
FDM First Trust Dow Jones Select M.. 0.60 %

N/A

 USD 0.18B

ETFs Containing VBR

ABCS Alpha Blue Capital US Sma.. 9.84 % 0.00 %

N/A

 USD 0.01B
FDVL 8.92 % 0.00 %

N/A

 N/A
GMOM 5.88 % 0.59 %

N/A

 N/A

Market Performance

  Market Performance vs. Industry/Classification (Small Value) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.62% 100% F 63% D
Dividend Return 0.52% 91% A- 31% F
Total Return 7.14% 100% F 62% D
Trailing 12 Months  
Capital Gain 22.87% 82% B 72% C
Dividend Return 2.47% 91% A- 37% F
Total Return 25.34% 82% B 71% C-
Trailing 5 Years  
Capital Gain 49.06% 70% C- 70% C-
Dividend Return 11.91% 90% A- 47% F
Total Return 60.97% 70% C- 69% C-
Average Annual (5 Year Horizon)  
Capital Gain 9.62% 45% F 72% C
Dividend Return 11.64% 64% D 72% C
Total Return 2.01% 91% A- 48% F
Risk Return Profile  
Volatility (Standard Deviation) 28.30% 82% B 40% F
Risk Adjusted Return 41.12% 64% D 68% D+
Market Capitalization 9.17B 100% F 95% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike